Outliving Your Ovaries - An Endocrinologist Weighs The Risks and Rewards of Treating Menopause with Hormone Therapy

Marina Johnson, M.D., F.A.C.E. a board-certified endocrinologist with 30 years of clinical experience treating over 100,000 female patient visits and Medical Director of the Institute of Endocrinology and Preventive Medicine in the Dallas-Ft Worth Metroplex. Dr. Johnson specializes in treating menopause and is the author of Outliving Your Ovaries™, a guidebook for women to help evaluate the risks and benefits of hormone replacement therapy.The Johnson Menopause Method™ is a better option than the current “standard of care” menopause treatments. Not treating menopause leads to an increased risk of heart disease, osteoporosis, Alzheimer’s disease, diabetes and colon cancer. Multiple clinical studies have shown Prempro®, still a commonly prescribed hormone therapy, is linked to an increased risk of breast cancer, heart disease, strokes, blood clots, incontinence and dementia. All estrogens carry risks but risks associated with topical bioidentical hormones are fewer. Compounded bioidentical hormones are not required to meet FDA standards for quality or efficacy; therefore, the need to use pharmaceutical bioidentical hormones.